DGXX vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

DGXX

65.9
AI Score
VS
HIVE Wins

HIVE

70.4
AI Score

Investment Advisor Scores

DGXX

Nov 10, 2026
66score
Recommendation
HOLD

HIVE

Nov 10, 2026
70score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DGXX HIVE Winner
Forward P/E 2.8711 62.8931 DGXX
PEG Ratio 0 0 Tie
Revenue Growth -18.3% 73.5% HIVE
Earnings Growth 0.0% -99.9% DGXX
Tradestie Score 65.9/100 70.4/100 HIVE
Profit Margin -114.8% -98.5% HIVE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

DGXX 1M: -28.5% · 3M: -48.4% HIVE 1M: -28.3% · 3M: -37.2%

Current Technical Phase

DGXX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.9%), weak momentum, RSI 37

RSI (14): 37.2 · Price: $2.16

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.4%), weak momentum, RSI 34

RSI (14): 34.3 · Price: $1.72

Fundamentals Snapshot

Metric DGXX HIVE
Market Cap — —
Forward P/E 108.0 -3.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.7%
Gross Margin 0.0% 0.4%
Operating Margin -2.3% -0.6%
EPS -0.57 -1.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.